Loading...
Publication
O impacto do farmacêutico na gestão da polifarmácia
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.68 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Introdução: A polifarmácia está a tornar-se cada vez mais presente na vida dos idosos, deste modo a intervenção farmacêutica pode apresentar um contributo bastante significativo, uma vez que permite que a terapêutica farmacológica seja realizada de forma mais adequada, segura e efetiva.
Objetivo: Discutir a importância que o farmacêutico tem e pode vir a ter na gestão da polimedicação; sustentar esse facto realizando a revisão farmacoterapêutica de 2 casos reais de doentes com polifarmácia em cenários distintos: um ambulatório e outro hospitalar.
Metodologia: Como critério de seleção da evidência científica, recorreu-se à análise de artigos publicados nos últimos dez anos com as palavras chave designadas. Realizou-se a revisão farmacoterapêutica de 2 casos reais de doentes com polifarmácia, em cenários diferentes: farmácia comunitária e Hospital. Na farmácia comunitária, a recolha de dados foi efetuada através de entrevista ao doente, no hospital a informação foi obtida através da leitura do processo clínico do doente. A recolha de dados foi realizada com recurso à
folha SOAP. Para realizar a revisão da medicação recorreu-se ao uso dos Critérios de Beers e START/STOPP no doente comunitário e, aos Critérios MAI no doente hospitalar. Utilizou-se o Consenso de Granada para identificar PRM. A revisão farmacoterapêutica foi realizada entre 23/07/2021 e 23/08/2021. O estudo foi aprovado pelas Comissões de Ética do Hospital Egas Moniz e do Instituto Universitário Egas Moniz. Os relatórios das revisões terapêuticas elaborados foram entregues aos Diretores Técnicos.
Conclusão: A polifarmácia representa um sério problema de saúde pública, no qual o farmacêutico pode ter um contributo bastante significativo na deteção e resolução de PRM e identificação de medicamentos potencialmente inapropriados.
Introduction: Polypharmacy is becoming increasingly present in the lives of the elderly, so pharmaceutical intervention can make a very significant contribution, since it allows pharmacological therapy to be performed in a more appropriate, safe, and effective way. Objective: Discuss the importance that the pharmacist has and may have in the management of polymedication; to sustain this fact by performing the pharmacotherapeutic review of 2 real cases of patients with polypharmacy in different scenarios: an outpatient clinic and a hospital. Methodology: As a criterion for selecting scientific evidence, we used the analysis of articles published in the last ten years with the designated keywords. A pharmacotherapeutic review of 2 real cases of patients with polypharmacy was performed in different scenarios: community pharmacy and hospital. In the community pharmacy, data were collected through an interview with the patient, in the hospital the information was obtained by reading the patient's clinical process. Data collection was performed using the SOAP sheet. To perform the medication review, the Beers and START/STOPP Criteria were used in the community patient and the MAI Criteria in the hospital patient. The Granada Consensus was used to identify PRM. The pharmacotherapeutic review was carried out between 23/07/2021 and 23/08/2021. The study was approved by the Ethics Committees of The Egas Moniz Hospital and the Egas Moniz University Institute. The reports of the therapeutic reviews prepared were delivered to the Technical Directors. Conclusion: Polypharmacy represents a serious public health problem, in which the pharmacist can make a very significant contribution in the identification and resolution of PRM and identification of potentially inappropriate medicines.
Introduction: Polypharmacy is becoming increasingly present in the lives of the elderly, so pharmaceutical intervention can make a very significant contribution, since it allows pharmacological therapy to be performed in a more appropriate, safe, and effective way. Objective: Discuss the importance that the pharmacist has and may have in the management of polymedication; to sustain this fact by performing the pharmacotherapeutic review of 2 real cases of patients with polypharmacy in different scenarios: an outpatient clinic and a hospital. Methodology: As a criterion for selecting scientific evidence, we used the analysis of articles published in the last ten years with the designated keywords. A pharmacotherapeutic review of 2 real cases of patients with polypharmacy was performed in different scenarios: community pharmacy and hospital. In the community pharmacy, data were collected through an interview with the patient, in the hospital the information was obtained by reading the patient's clinical process. Data collection was performed using the SOAP sheet. To perform the medication review, the Beers and START/STOPP Criteria were used in the community patient and the MAI Criteria in the hospital patient. The Granada Consensus was used to identify PRM. The pharmacotherapeutic review was carried out between 23/07/2021 and 23/08/2021. The study was approved by the Ethics Committees of The Egas Moniz Hospital and the Egas Moniz University Institute. The reports of the therapeutic reviews prepared were delivered to the Technical Directors. Conclusion: Polypharmacy represents a serious public health problem, in which the pharmacist can make a very significant contribution in the identification and resolution of PRM and identification of potentially inappropriate medicines.
Description
Dissertação para obtenção do grau de Mestre no Instituto Universitário Egas Moniz
Keywords
Polifarmácia Farmacêutico Revisão farmacoterapêutica Medicação inapropriada